Ovares-SR Tablet contains Dehydroepiandrosterone (Micronized) 75 mg and Folic Acid 0.1 mg, formulated to support hormonal balance and reproductive health. Dehydroepiandrosterone (DHEA) is an endogenous steroid hormone precursor involved in the biosynthesis of androgens and estrogens, playing a crucial role in maintaining endocrine function, particularly in women with diminished ovarian reserve or adrenal insufficiency. The micronized form enhances bioavailability, ensuring effective systemic absorption. Folic acid, a vital B-vitamin, is essential for DNA synthesis, cell division, and proper fetal development, thereby reducing the risk of neural tube defects during pregnancy. Ovares-SR is primarily indicated for women experiencing infertility related to hormonal imbalance, diminished ovarian function, or those preparing for conception to improve ovulatory function and enhance reproductive outcomes. It may also be used as an adjunct in managing conditions associated with low endogenous DHEA levels. Administration should follow medical guidance, considering patient-specific factors such as age, hormonal status, and reproductive goals. Contraindications include hypersensitivity to components, hormone-sensitive malignancies, and pregnancy without medical supervision. Common adverse effects are generally mild and may include gastrointestinal discomfort or hormonal fluctuations. Regular monitoring of hormonal levels and clinical response is recommended to optimize therapy and ensure safety.